XXZ-24287-96385

4 vaccinations 9 coded responses 53 check-ins 9 free-text entries 3 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 730 / OK
Registered: 2021-03-04

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-04
Registered in v-safe
2021-03-04
Dose 1 — Pfizer-BioNTech
2021-03-04
Health check-in — 0 day, dose 1
Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-05
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · Fatigue or tiredness

Adult check-in
2021-03-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-03-11
Health check-in — 7 day, dose 1
Feeling: Good · None

Adult check-in
2021-03-18
Health check-in — 14 day, dose 1
Feeling: Good

Adult check-in
2021-03-25
Health check-in — 21 day, dose 1
Feeling: Good

Adult check-in
2021-03-26
Dose 2 — Pfizer-BioNTech
2021-03-26
Health check-in — 0 day, dose 2
Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-27
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Oropharyngeal pain, Palpitations — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-27
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-28
Survey response — days 1–6 daily, dose 2
MedDRA: Dyspnoea, Oropharyngeal pain, Sinus pain — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-29
Survey response — days 1–6 daily, dose 2
MedDRA: Office visit — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-29
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-03-30
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

MedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
2021-03-31
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Headache, Joint pains, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Adult check-in
2021-04-01
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-04-02
Health check-in — 7 day, dose 2
Feeling: Good · None

Adult check-in
2021-04-09
Health check-in — 14 day, dose 2
Feeling: Good

Adult check-in
2021-04-18
Health check-in — 21 day, dose 2
Feeling: Good

Adult check-in
2021-04-23
Health check-in — 28 day, dose 2
Feeling: Good

Adult check-in
2021-04-30
Health check-in — 35 day, dose 2
Feeling: Good

Adult check-in
2021-05-07
Health check-in — 42 day, dose 2
Feeling: Good

Adult check-in
2021-06-25
Health check-in — 3 month, dose 2
Feeling: Good

Adult check-in
2021-09-24
Health check-in — 6 month, dose 2
Feeling: Good

Adult check-in
2021-11-15
Dose 3 — Pfizer-BioNTech
Co-administered: Flu
2021-11-15
Health check-in — 0 day, dose 3
Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-11-16
Survey response — days 1–6 daily, dose 3
MedDRA: Sensitive skin — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11 · check-in answers available
2021-11-17
Survey response — days 1–6 daily, dose 3
MedDRA: Oropharyngeal pain, Pain of skin — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11 · check-in answers available
2021-11-18
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-11-19
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-11-20
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2021-11-21
Health check-in — days 1–6 daily, dose 3
Feeling: Good · None

Adult check-in
2021-11-22
Health check-in — 7 day, dose 3
Feeling: Good · None

Adult check-in
2021-11-29
Health check-in — 14 day, dose 3
Feeling: Good

Adult check-in
2021-12-06
Health check-in — 21 day, dose 3
Feeling: Good

Adult check-in
2021-12-13
Health check-in — 28 day, dose 3
Feeling: Good

Adult check-in
2021-12-20
Health check-in — 35 day, dose 3
Feeling: Good

Adult check-in
2021-12-27
Health check-in — 42 day, dose 3
Feeling: Good

Adult check-in
2022-02-14
Survey response — 3 month, dose 3
MedDRA: COVID-19, Erythema infectiosum, Exposure to SARS-CoV-2, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

MedDRA releases: 2024-11 · check-in answers available
2022-02-14
Report sent to call center — 3 month, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2022-02-15
Call successful
Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-05-16
Health check-in — 6 month, dose 3
Feeling: Good

Adult check-in
2022-09-19
Dose 4 — Pfizer-BioNTech
2022-09-19
Survey response — 0 day, dose 4
MedDRA: Thirst — Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

MedDRA releases: 2024-11 · check-in answers available
2022-09-20
Survey response — days 1–6 daily, dose 4
MedDRA: Abdominal pain, Asthma, Dizziness, Oropharyngeal pain, Pre-existing disease, Pruritus, Thirst — Feeling: Poor · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

MedDRA releases: 2024-11 · check-in answers available
2022-09-21
Health check-in — days 1–6 daily, dose 4
Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities

Adult check-in
2022-09-22
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Site: Pain · Headache, Joint pains, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-09-23
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Joint pains, Fatigue or tiredness

Adult check-in
2022-09-24
Health check-in — days 1–6 daily, dose 4
Feeling: Good · Fatigue or tiredness

Adult check-in
2022-09-25
Health check-in — days 1–6 daily, dose 4
Feeling: Good · None

Adult check-in
2022-09-27
Health check-in — 7 day, dose 4
Feeling: Good · None

Adult check-in
2022-10-03
Health check-in — 14 day, dose 4
Feeling: Good

Adult check-in
2022-10-10
Health check-in — 21 day, dose 4
Feeling: Good

Adult check-in
2022-10-20
Health check-in — 28 day, dose 4
Feeling: Good

Adult check-in
2022-10-24
Health check-in — 35 day, dose 4
Feeling: Good

Adult check-in
2022-10-31
Health check-in — 42 day, dose 4
Feeling: Good

Adult check-in
2022-12-19
Health check-in — 3 month, dose 4
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-04	Pfizer-BioNTech
2	2021-03-26	Pfizer-BioNTech
3	2021-11-15	Pfizer-BioNTech	Flu
4	2022-09-19	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2021-03-27	Successful	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2021-03-29	Successful	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)
2022-02-14	Successful 2022-02-15	Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Free text

Release 6

Systemic reaction (other): Shortness of breath, sore throat, heart palpitations

Systemic reaction (other): Sore throat, sinus pain, shortness of breath

Healthcare visit (other): County health dept. nurse to report adverse effects

Systemic reaction (other): Dizziness

Release 10

Systemic reaction (other): Skin extremely sensitive to touch

Systemic reaction (other): Mild Sore throat, skin is painful to touch

Release 11

Symptoms: COVID-19 and Fifth Disease; originally exposed to COVID-19 around Jan 11, never tested positive, 2.5 weeks later my mom tested positive; still have cough and fatigue

Release 12

Systemic reaction (other): Extremely thirsty

Systemic reaction (other): Extremely thirsty, slight dizziness, itchy, sore throat, flared asthma a little last night and this morning, abdominal pain was "stabby"

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Office visit	✓	✓	✓
SD	COVID-19	·	·	✓
SD	Erythema infectiosum	·	·	✓
SD	Exposure to SARS-CoV-2	·	·	✓
SD	SARS-CoV-2 test negative	·	·	✓
SRO	Abdominal pain	·	·	✓
SRO	Asthma	·	·	✓
SRO	Dizziness	✓	✓	✓
SRO	Dyspnoea	✓	✓	✓
SRO	Oropharyngeal pain	✓	✓	✓
SRO	Pain of skin	·	·	✓
SRO	Palpitations	✓	✓	✓
SRO	Pre-existing disease	·	·	✓
SRO	Pruritus	·	·	✓
SRO	Sensitive skin	·	·	✓
SRO	Sinus pain	✓	✓	✓
SRO	Thirst	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release